| 摘要 |
The present invention provides a method for treating a hyperkinetic movement disorder in a human patient. The method comprises administering to a patient an effective amount of amantadine, or a salt thereof, and an effective amount of a tetrabenazine compound selected from the group consisting of tetrabenazine, dihydrotetrabenazine, a salt thereof, an isomer thereof, and a combination thereof. The methods of the present invention are particularly useful in treating chorea, tardive dyskinesia, or Tourette's syndrome. The present invention further provides a pharmaceutical composition comprising an effective amount of amantadine and an effective amount of a tetrabenazine compound. |
